ServicenavigationHauptnavigationTrailKarteikarten

Research unit
INNOSUISSE
Project number
100.087 IP-LS
Project title
Preclinical development of an innovative drug candidate, TOP-V122, for the treatment of lung fibrosis. (Innolink: 100.087 IP-LS)

Participants

Research organisation: Innosuisse
Swiss Innovation Agency
Einsteinstrasse 2
CH-3003 Bern
+41 58 461 61 61 (Call Center)
info@innosuisse.ch
www.innosuisse.ch/
Contact person

 Bhide Yoshita
Topadur Pharma AG
www.uid.admin.ch/Detail.aspx?uid_id=CHE481951668

Scientific management
Universität Zürich

Implementation Partner


Topadur Pharma AG
www.uid.admin.ch/Detail.aspx?uid_id=CHE481951668